Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study) von Heimans, Lotte, Akdemir, Gülşah, Boer, Kirsten V C Wevers-de, Goekoop-Ruiterman, Yvonne P, Molenaar, Esmeralda T, van Groenendael, Johannes H L M, Peeters, Andreas J, Steup-Beekman, Gerda M, Lard, Leroy R, de Sonnaville, Peter B J, Grillet, Bernard A M, Huizinga, Tom W J, Allaart, Cornelia F

Volltext

Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study) von Wevers-de Boer, Kirsten, Visser, Karen, Heimans, Lotte, Ronday, H Karel, Molenaar, Esmeralda, Groenendael, J Hans L M, Peeters, André J, Westedt, Marie-Louise, Collée, Gerard, de Sonnaville, Peter B J, Grillet, Bernard A M, Huizinga, Tom W J, Allaart, Cornelia F

Volltext

Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the... von de Jong, Pascal H P, Hazes, Johanna M, Buisman, Leander R, Barendregt, Pieternella J, van Zeben, Derkjen, van der Lubbe, Peter A, Gerards, Andreas H, de Jager, Mike H, de Sonnaville, Peter B J, Grillet, Bernard A, Luime, Jolanda J, Weel, Angelique E A M

Volltext

Do we need to lower the cut point of the 2010 ACR/EULAR classification criteria for diagnosing rheumatoid arthritis? von van der Ven, Myrthe, Alves, Celina, Luime, Jolanda J, Gerards, Andreas H, Barendregt, Pieternella J, van Zeben, Derkjen, van Schaeybroeck, Barbara, de Sonnaville, Peter B J, Grillet, Bernard A, Hazes, Johanna M W

Volltext

Cost‐utility analysis of treatment strategies in patients with recent‐onset rheumatoid arthritis von Van den Hout, Wilbert B., Goekoop‐Ruiterman, Yvonne P. M., Allaart, Cornelia F., De Vries‐Bouwstra, Jeska K., M. Hazes, J. Mieke, Kerstens, Pit J. S. M., Van Zeben, Derkjen, Hulsmans, Harry M. J., De Jonge‐Bok, Johanna M., De Sonnaville, Peter B. J., Dijkmans, Ben A. C., Breedveld, Ferdinand C.

Volltext

Two-year results of disease activity score von Heimans, Lotte, Akdemir, GulAah, Boer, Kirsten V. C. Wevers-de, Goekoop-Ruiterman, Yvonne P, Molenaar, Esmeralda T, van Groenendael, Johannes H. L. M, Peeters, Andreas J, Steup-Beekman, Gerda M, Lard, Leroy R, de Sonnaville, Peter B. J, Grillet, Bernard A. M, Huizinga, Tom W. J, Allaart, Cornelia F

Volltext

Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study von de Jong, Pascal Hendrik Pieter, Quax, Rogier A, Huisman, Margriet, Gerards, A H, Feelders, Richard A, de Sonnaville, Peter B, Luime, Jolanda J, Weel, Angelique E, Hazes, J M

Volltext

Treatment decisions and related costs differ significantly depending on the choice of a disease activity index in RA, according to 1987 and 2010 classification criteria von DE JONG, Pascal H. P, HAZES, Johanna M. W, ZEBEN, Derkjen Van, DER LUBBE, Peter A. Van, DE JAGER, Mike H, DE SONNAVILLE, Peter B, LUIME, Jolanda J, WEEL, Angelique E. A. M

Volltext